Skip to content
lifestyle.presbycamp.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Abbott
Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment
October 26, 2026
Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer
October 23, 2026
Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
October 21, 2026
Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
October 21, 2026
Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop
October 7, 2026
Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
October 5, 2026
Abbott hosts conference call for third-quarter earnings
September 30, 2026
Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
September 30, 2026
Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
September 23, 2026
Abbott declares 411th consecutive quarterly dividend
September 17, 2026
1
2
3
Next Page
→